CMO
Elumn8 Medical, Inc.
CAMPBELL, California, United States
John B. Simpson, PhD, MD, has revolutionized medicine through innovations that have fundamentally altered how physicians treat cardiovascular disease. Dr. Simpson has founded several companies dedicated to providing patients with the most cutting-edge therapies across a range of areas, including directional atherectomy (coronary and peripheral), chronic total occlusions (CTOs), ultrasound, percutaneous transluminal coronary angioplasty, suture-mediated vascular closure, and local drug delivery. He received his PhD in Immunology from the University of Texas and his MD from Duke University School of Medicine and completed his fellowship in interventional cardiology at Stanford University. Today, he focuses his efforts on developing devices to radically improve the treatment of vascular disease by advancing new technologies and approaches in optics, automation, and software engineering.
Disclosure(s): No financial relationships to disclose
Sunday, March 8, 2026
12:19 PM - 12:23 PM EST